Login
|
Register
News
Media
Insights
Peer Exchange
OncNurse TV
Webinars
Podcasts
Resources
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancers
Supportive Care
Blood Cancers
Prevention
Genetics
Nurse Navigation
Immuno-Oncology
Drug Safety
Skin Cancer/Melanoma
Brain Cancer
Childhood/AYA Cancer
Head and Neck Cancers
Adverse Event Management
Contributors
Conferences
Partners
Advocacy
Associations
Schools of Nursing
Publications
CE
Register now to learn about a new option for relapsed or refractory follicular lymphoma
Head and Neck Cancers
Nivolumab Plus Chemotherapy Improves Survival Outcomes in Gastric and Esophageal Cancers
BY KRISTI ROSA
FDA Expands Gardasil 9 Approval for HPV-Related Cancers
BY BRIELLE BENYON
Expert Discusses Updates in Thyroid Cancer
BY MARCIA BROSE, MD, PHD
FDA Approves Pembrolizumab for Esophageal Cancer Subgroup
BY BRIELLE BENYON
Oncology Nurses Are Key in Head and Neck Cancer Care
BY MICHAEL G. MOORE, MD
FDA Approves Pembrolizumab Regimens for HNSCC
BY BRIELLE BENYON
Eliminating Gender-Based Barriers to Immunotherapy
BY KATIE KOSKO
Low-Dose Drug Regimen Is Effective for Older, Frail Patients With Gastroesophageal Cancer
BY BRIELLE BENYON
Twitter Lends Insight to HPV-Associated Oral Cancer Knowledge
BY BRIELLE BENYON
Preventing Radiation Dermatitis
BY RAYMOND CHAN, PHD, RN, BN, MAPPSC
Next Page >>
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources
Newsroom
Continuing Education
Discussions
Web Exclusives
About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.